Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J St-Louis

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 2, 2018
A prospective surveillance study of inhibitor development in haemophilia A patients following a population switch to a third-generation B-domain-deleted recombinant factor VIIIE Dubé, A Bonnefoy, C Merlen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 28, 2015
Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia AR Kruse-Jarres, J St-Louis, A Greist, et al.
Breast (Edinburgh, Scotland)|November 29, 2016
Real world patterns of care in HER2-overexpressing breast cancer: Results of a survey of TEACH clinical trial investigators in 2011Y Chavarri-Guerra, J St Louis, A Bukowski, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 2, 2018
A prospective surveillance study of inhibitor development in haemophilia A patients following a population switch to a third-generation B-domain-deleted recombinant factor VIIIE Dubé, A Bonnefoy, C Merlen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 28, 2015
Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia AR Kruse-Jarres, J St-Louis, A Greist, et al.
Breast (Edinburgh, Scotland)|November 29, 2016
Real world patterns of care in HER2-overexpressing breast cancer: Results of a survey of TEACH clinical trial investigators in 2011Y Chavarri-Guerra, J St Louis, A Bukowski, et al.
Pageof 12